Format

Send to

Choose Destination
Expert Rev Vaccines. 2017 Feb;16(2):81-83. doi: 10.1080/14760584.2017.1268921. Epub 2016 Dec 15.

Vaccine against toxic shock syndrome in a first-in-man clinical trial.

Author information

1
a Biomedizinische ForschungsgmbH , Vienna , Austria.
2
b Department of Clinical Pharmacology , Medical University of Vienna , Vienna , Austria.

KEYWORDS:

Staphylococcus aureus; bacterial infection; first-in-man clinical trial; toxic shock syndrome; toxoid vaccine

PMID:
27918218
DOI:
10.1080/14760584.2017.1268921
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center